← Browse by Condition
Medical Condition

oral lichen planus

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for oral lichen planus sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — oral lichen planus Clinical Trials

How many clinical trials are currently recruiting for oral lichen planus?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for oral lichen planus, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for oral lichen planus?
oral lichen planus research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a oral lichen planus clinical trial?
Eligibility criteria for oral lichen planus trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Laboratoires Elerte 1 trial
University of Erlangen-Nürnberg Medical School 1 trial
Peking University Third Hospital 1 trial
Cairo University 1 trial

Recruiting Clinical Trials

NCT07620353
Recruiting
Observational Study of OROSEDAL in Sore Throat and Minor Oral Lesions
Enrollment
124 pts
Location
France
Sponsor
Laboratoires Elerte
View Trial →
NCT03975322
Recruiting
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
Enrollment
500 pts
Location
Germany
Sponsor
University of Erlangen-Nürnber...
View Trial →
NCT05973097
Recruiting
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Enrollment
156 pts
Location
China
Sponsor
Peking University Third Hospit...
View Trial →
NCT06981767 Phase 2
Recruiting
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Enrollment
42 pts
Location
Egypt
Sponsor
Cairo University
View Trial →

Related Conditions

sore throat (1) aphthous ulcer (1) minor mouth lesion (1) oral pain (1) oral leukoplakia (1) oral leukoplakia of tongue (1) oral leukoplakia of gingiva (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology